Intervention not reported
Adverse events ‐ myopathy · people with cardiovascular disease or at high risk of cardiovascular disease
It is very uncertain whether the intervention changes adverse events ‐ myopathy (very low certainty).
1 finding from 1 review
- Ezetimibe for the prevention of cardiovascular disease and all‐cause mortality events 2018 · Cochrane Headline outcomes onlyRR 1.31 [0.72, 2.38]3 studies · 20581 participantsVery low